APRINOIA Therapeutics Statistics
Total Valuation
APRI has a market cap or net worth of $335.24 million. The enterprise value is $342.45 million.
Market Cap | 335.24M |
Enterprise Value | 342.45M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
APRI has 27.94 million shares outstanding.
Shares Outstanding | 27.94M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 36.71 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 37.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.47 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $126,847 |
Profits Per Employee | -$301,944 |
Employee Count | 72 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, APRI has paid $64,000 in taxes.
Income Tax | 64,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, APRI had revenue of $9.13 million and -$21.74 million in losses. Loss per share was -$0.78.
Revenue | 9.13M |
Gross Profit | 9.13M |
Operating Income | -21.16M |
Pretax Income | -21.68M |
Net Income | -21.74M |
EBITDA | -19.63M |
EBIT | -20.18M |
Loss Per Share | -$0.78 |
Balance Sheet
The company has $8.39 million in cash and $15.60 million in debt, giving a net cash position of -$7.20 million or -$0.26 per share.
Cash & Cash Equivalents | 8.39M |
Total Debt | 15.60M |
Net Cash | -7.20M |
Net Cash Per Share | -$0.26 |
Equity / Book Value | -81.39M |
Book Value Per Share | -2.91 |
Working Capital | -20.96M |
Cash Flow
In the last 12 months, operating cash flow was -$12.88 million and capital expenditures -$1.26 million, giving a free cash flow of -$14.14 million.
Operating Cash Flow | -12.88M |
Capital Expenditures | -1.26M |
Free Cash Flow | -14.14M |
FCF Per Share | -$0.51 |
Margins
Gross margin is 100.00%, with operating and profit margins of -231.67% and -238.04%.
Gross Margin | 100.00% |
Operating Margin | -231.67% |
Pretax Margin | -237.34% |
Profit Margin | -238.04% |
EBITDA Margin | -214.98% |
EBIT Margin | -220.94% |
FCF Margin | -154.81% |
Dividends & Yields
APRI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -6.48% |
FCF Yield | -4.22% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |